Specialty pharmaceuticals company Akorn has announced the signing of a five-year commercial manufacturing and supply agreement with a US ophthalmic company.
Subscribe to our email newsletter
Under the terms of the five-year agreement, Akorn will be responsible for the exclusive manufacturing and supply of three OTC eye care products. The line of products will be manufactured at the company’s Decatur, Illinois production facility and are targeted for distribution in the US and world wide markets.
Arthur Przybyl, Akorn’s president and CEO, said: “This partnership reflects company’s strong commitment to bringing high quality contract manufacturing services to the ophthalmic industry. We look forward to working closely with our partner to commercialize their OTC line of products.”
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.